NEW YORK (GenomeWeb) – Opko Health reported after the close of the markets Monday that its first quarter revenues jumped ninefold compared to Q1 2015. The company said the surge was due in large part to revenues from clinical lab Bio-Reference Laboratories, which Opko acquired in August 2015.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.